Synthesis and Structure-Activity Relationship Study of 1-Phenyl-1-(quinazolin-4-yl)ethanols as Anticancer Agents

被引:37
作者
Kuroiwa, Kenta [1 ]
Ishii, Hirosuke [2 ]
Matsuno, Kenji [2 ]
Asai, Akira [2 ]
Suzuki, Yumiko [1 ]
机构
[1] Sophia Univ, Fac Sci & Technol, Dept Mat & Life Sci, Chiyoda Ku, Tokyo 1028554, Japan
[2] Univ Shizuoka, Grad Sch Pharmaceut Sci, Suruga Ku, Shizuoka 4228526, Japan
来源
ACS MEDICINAL CHEMISTRY LETTERS | 2015年 / 6卷 / 03期
关键词
Quinazoline; anticancer; tubulin inhibitor; colchicine binding site; structure-activity relationship study; TUBULIN; QUINAZOLINES; COLCHICINE; DISCOVERY; BINDING;
D O I
10.1021/ml5004684
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A quinazoline derivative PVHD121 (1a) was shown to have strong antiproliferative activity against various tumor-derived cell lines, including A549 (lung), NCI-H460 (lung), HCT116 (colon), MCF7 (breast), PC3 (prostate), and HeLa (cervical) cells with IC50 values from 0.1 to 0.3 mu M. A structure activity relationship (SAR) study at the 2- and 4-position of the quinazoline core lead to the discovery of more potent anticancer agents (14, 16, 17, 19, 24, and 31). The results of an in vitro tubulin polymerization assay and fluorescent based colchicine site competition assay with purified tubulin indicated that la inhibits tubulin polymerization by binding to the colchicine site.
引用
收藏
页码:287 / 291
页数:5
相关论文
共 20 条
[1]   Microtubule-associated proteins as targets in cancer chemotherapy [J].
Bhat, Kumar M. R. ;
Setaluri, Vijayasaradhi .
CLINICAL CANCER RESEARCH, 2007, 13 (10) :2849-2854
[2]   PROMOTION OF FLUORESCENCE UPON BINDING OF COLCHICINE TO TUBULIN [J].
BHATTACH.B ;
WOLFF, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1974, 71 (07) :2627-2631
[3]  
Davis Ashley, 1999, Neoplasia (New York), V1, P498
[4]   A History of Cancer Chemotherapy [J].
DeVita, Vincent T., Jr. ;
Chu, Edward .
CANCER RESEARCH, 2008, 68 (21) :8643-8653
[5]   A combinatorial scaffold approach toward kinase-directed heterocycle libraries [J].
Ding, S ;
Gray, NS ;
Wu, X ;
Ding, Q ;
Schultz, PG .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2002, 124 (08) :1594-1596
[6]   2-Chloroquinazoline. Synthesis and reactivity of a versatile heterocyclic building block [J].
Henriksen, Signe Teuber ;
Sorensen, Ulrik Svane .
TETRAHEDRON LETTERS, 2006, 47 (47) :8251-8254
[7]   Understanding microtubule dynamics for improved cancer therapy [J].
Honore, S ;
Pasquier, E ;
Braguer, D .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2005, 62 (24) :3039-3056
[8]   Structure-activity relationships of ustiloxin analogues [J].
Joullie, Madeleine M. ;
Berritt, Simon ;
Hamel, Ernest .
TETRAHEDRON LETTERS, 2011, 52 (17) :2136-2139
[9]   Toward Highly Potent Cancer Agents by Modulating the C-2 Group of the Arylthioindole Class of Tubulin Polymerization Inhibitors [J].
La Regina, Giuseppe ;
Bai, Ruoli ;
Rensen, Whilelmina Maria ;
Di Cesare, Erica ;
Coluccia, Antonio ;
Piscitelli, Francesco ;
Famiglini, Valeria ;
Reggio, Alessia ;
Nalli, Marianna ;
Pelliccia, Sveva ;
Da Pozzo, Eleonora ;
Costa, Barbara ;
Granata, Ilaria ;
Porta, Amalia ;
Maresca, Bruno ;
Soriani, Alessandra ;
Iannitto, Maria Luisa ;
Santoni, Angela ;
Li, Junjie ;
Cona, Marlein Miranda ;
Chen, Feng ;
Ni, Yicheng ;
Brancale, Andrea ;
Dondio, Giulio ;
Vultaggio, Stefania ;
Varasi, Mario ;
Mercurio, Ciro ;
Martini, Claudia ;
Hamel, Ernest ;
Lavia, Patrizia ;
Novellino, Ettore ;
Silvestri, Romano .
JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (01) :123-149
[10]   Quinazoline derivatives as potential anticancer agents: a patent review (2007-2010) [J].
Marzaro, Giovanni ;
Guiotto, Adriano ;
Chilin, Adriana .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2012, 22 (03) :223-252